Document is current
Any future updates will be listed below
-
Authors
Ward, Thomas R.
Qu, Ping-Ping https://orcid.org/0000-0003-2487-5402
Leung, Louis C.
Zhou, Bo
Muench, Kristin L.
Khechaduri, Arineh
Plastini, Melanie J.
Charlton, Carol A.
Pattni, Reenal
Ho, Steve
Ho, Marcus
Huang, Yiling
Zhou, Patrick https://orcid.org/0009-0004-4790-6616
Hallmayer, Joachim F.
Mourrain, Philippe
Palmer, Theo D.
Zhang, Xianglong https://orcid.org/0000-0003-0977-5673
Urban, Alexander E. https://orcid.org/0000-0001-9772-933X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01MH129758)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH108659)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (DP2 MH100010-01)
- License Information
-
More Information
Article History
Received: 29 July 2024
Revised: 3 January 2025
Accepted: 15 April 2025
First Online: 15 May 2025
Competing interests
: The authors declare no competing interests.
: The distribution of iPSC cell lines used in this study is by permission from the Simons Foundation Autism Research Initiative (SFARI). The research protocol is approved by the Institutional Review Board (IRB) of Stanford University under the IRB number IRB-12481 and the title “Using induced pluripotent stem cells to unravel the neuronal phenotypes of autism spectrum disorders”.
